Steven Tipper

Steven Tipper

Auto-generated profile, based on publicly available information

Steven Tipper

23 Strands Pty Ltd, Pyrmont, Australia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Hepatology
Verified
Journal Article
Closed access
MRMonica C. Robotin
Monica C. Robotin
MKMelanie Kansil
Melanie Kansil
KHKirsten Howard
Kirsten Howard
JGJacob George
Jacob George
STSteven Tipper
Steven Tipper
APAndrew G. Penman
Andrew G. Penman

1 January 2007 in Medical Informatics and the Internet in Medicine
Verified
Journal Article
Closed access
VSVitali Sintchenko
Vitali Sintchenko
FMFarah Magrabi
Farah Magrabi
STSteven Tipper
Steven Tipper
Previous reviews of electronic decision-support systems (EDSS) have often treated them as a single category, and factors that may modify their effectiveness of EDSS have not been examined. The objective was to summarise the evidence associating the use of computerised decision support and improved patient outcomes. PubMed/Medline and the Database of Abstracts were searched for randomised controlled trials (RCT) of EDSS from 1 January 1994 to 31 January 2006. Twenty-four RCT studies from 97 reviewed were selected, eight of them examined systems supporting decisions for patients who presented with an acute illness, and 16 studies enrolled patients with chronic conditions. Overall, 13 (54%) of the studies showed a positive result, and 11 (46%) were with no impact. Critiquing and consultative systems showed the impact in 71% and 47% of studies, respectively. All systems targeting decisions related to acute disease improved patient outcomes compared with 38% of systems focused on the management of chronic conditions (P = 0.005). Provision of EDSS improves prescribing practices and treatment outcomes of patients with acute illnesses; however, EDSS were less effective in primary care. Complex interventions as clinical EDSS may require new metrics of assessment to describe the impact on patient outcomes.

21 July 2010 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MRMonica C Robotin
Monica C Robotin
MKMelanie Q Kansil
Melanie Q Kansil
JGJacob George
Jacob George
KHKirsten Howard
Kirsten Howard
STSteven Tipper
Steven Tipper
APAndrew G Penman
Andrew G Penman
Australians born in countries where hepatitis B infection is endemic are 6-12 times more likely to develop hepatocellular cancer (HCC) than Australian-born individuals. However, a program of screening, surveillance and treatment of chronic hepatitis B (CHB) in high risk populations could significantly reduce disease progression and death related to end-stage liver disease and HCC. Consequently we are implementing the B Positive pilot project, aiming to optimise the management of CHB in at-risk populations in south-west Sydney. Program participants receive routine care, enhanced disease surveillance or specialist referral, according to their stage of CHB infection, level of viral load and extent of liver injury. In this paper we examine the program's potential impact on health services utilisation in the study area.

1 April 2004 in Australian Journal of Primary Health
Verified
Journal Article
Closed access
PDF file
PBPatrick Gm Bolton
Patrick Gm Bolton
STSteven W Tipper
Steven W Tipper
JTJudith L Tasker
Judith L Tasker
This paper describes a Quality Use of Medicines program, addressing polypharmacy in the elderly through a quality assurance program that assisted GPs to improve their prescribing through medication reviews. Sixty-two GPs from four Divisions of General Practice each enrolled up to 12 of their patients aged over 65 for medication review. Data about the total number of medications, and number and dosage of selected cardiovascular and psychotropic medications taken by these patients, were collected. A statistically significant reduction in the total number of medications (p < 0.00005), and the dose (p = 0.028) and number (p = 0.0077) of benzodiazepines, and an increase in the number of Selective Serotonin Reuptake Inhibitors (SSRI) antidepressants (p = 0.0075) were observed. We conclude that these results suggest that medication review by GPs on patients who have complex care needs can be associated with a reduction in the median number of medications that these patients take.

9 February 2022 in Biophysical Reviews
Verified
Journal Article
Open access
PDF file
MGMark Grosser
Mark Grosser
HLH. Lin
H. Lin
MWM. Wu
M. Wu
YZY. Zhang
Y. Zhang
STS. Tipper
S. Tipper
CRCristobal Dos Remedios
Cristobal Dos Remedios
As developments in artificial intelligence and machine learning become more widespread in healthcare, their potential to transform clinical outcomes also increases. Peripartum cardiomyopathy is a rare and poorly-characterised condition that presents as heart failure in the last trimester prior to delivery or within 5–6 months postpartum. The lack of a definitive understanding of the molecular causes and clinical progress of this condition suggests that bibliometrics will be well-suited to creating new insights into this serious clinical problem. We examine similarities and differences between peripartum and its closely related familial dilated cardiomyopathy and idiopathic dilated cardiomyopathy. Using PubMed as the source of bibliometric data, we apply artificial intelligence–supported natural language processing to compare extracted data and genes association with these cardiomyopathies. Gene data were enhanced with additional metadata from third-party datasets and then analysed for their impact and specificity for peripartum cardiomyopathy. Artificial intelligence identified 14 genes that distinguished peripartum from both dilated and familial dilated cardiomyopathy. They are as follows: CTSD, RLN2, MMP23B*, SLC17A5, ST2*, PTHLH, CFH*, CFI, GPT, MR1, Rln1, SRI, STAT5A* and THBD. We then used the Human Protein Atlas website that uses affinity-purified rabbit polyclonal antibodies to identify genes that are expressed at the protein level (bold), or as RNA transcripts (*) in healthy human left ventricles. Additional analysis focussed on the full set of peripartum genes on linkage and specificity to cardiomyopathy yielded a different set of thirteen genes (bold font indicates those expressed in cardiomyocytes: PRL, RLN2, PLN, ST2, CTSD, F2, ACE, STAT3, TTN, SPP1, LGALS3, miR-146a, GNB3, SRI). This type of analysis can highlight new avenues for research, aimed at improving genomics-driven peripartum cardiomyopathy diagnosis as well as potential pathological and clinical sub-classification. We expect that this will allow for future improvements in identification, treatment and management of this condition. The first step in the application of these bibliometric-based artificial intelligence methods is to understand the current knowledge, and it is the aim of this paper to show how this might be achieved.

1 September 2001 in Australian Health Review
Verified
Journal Article
Closed access
PDF file
JTJudith Tasker
Judith Tasker
RWRob Wiseman
Rob Wiseman
PBPatrick Bolton
Patrick Bolton
STSteven Tipper
Steven Tipper
DiNCQUMGP (Divisions National Consortium for the Quality Use of Medicines in General Practice) reports on acollaboration between doctors, pharmaceutical companies, government agencies, and medicine users to managepolypharmacy (prescribing multiple medicines to a patient) amongst older people.We have reported the outcomes of our collaboration (improving the Quality Use of Medicines) elsewhere. Here wediscuss how we worked together, opened up new opportunities, and learned from one another. The first part of thisarticle outlines a constructive new way of thinking about collaborating, that we argue is fundamentally different fromcurrent approaches. The second part describes what we did in the words of those involved.